LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

CCL23 is a promising biomarker of injury in patients with ischaemic stroke

Photo by solenfeyissa from unsplash

Pathophysiological evidences on ischemic stroke (IS) indicate a critical involvement of post-ischemic inflammation in determining neuronal injury. In last decades, several inflammatory molecules have been investigated as potential diagnostic and/or… Click to show full abstract

Pathophysiological evidences on ischemic stroke (IS) indicate a critical involvement of post-ischemic inflammation in determining neuronal injury. In last decades, several inflammatory molecules have been investigated as potential diagnostic and/or prognostic tools. At present, however, no specific pathophysiological factor has been identified for being recommended in the clinical management of the disease. This article is protected by copyright. All rights reserved.

Keywords: injury patients; promising biomarker; patients ischaemic; ccl23 promising; injury; biomarker injury

Journal Title: Journal of Internal Medicine
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.